Respiratory Virus Vaccines: Pathways to Recommendations and Enhanced Coverage for At-Risk Populations
Abstract While marked differences exist between influenza virus, respiratory syncytial virus (RSV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is substantial overlap in the vulnerability of populations most at risk for severe disease following infection, chief among them...
Saved in:
Main Authors: | Stefania Maggi, Odile Launay, Rachel Dawson |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2024-12-01
|
Series: | Infectious Diseases and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40121-024-01082-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Foreword: Prevention of COVID-19, Influenza, and Respiratory Syncytial Virus in At-Risk Populations
by: Stefan Gravenstein
Published: (2024-12-01) -
Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
by: Alexander Domnich, et al.
Published: (2025-01-01) -
The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review
by: Roberto Debbag, et al.
Published: (2024-12-01) -
Recommendation for the use of respiratory syncytial virus vaccines
by: Ping-Ing Lee, et al.
Published: (2025-02-01) -
Prevention of respiratory syncytial virus infection in children. Recommendations of the Polish Society of Paediatrics and the National Paediatric Consultant
by: Teresa Jackowska, et al.
Published: (2024-12-01)